Graham Capital Management’s Verona Pharma VRNA Stock Holding History

Graham Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,909	Closed	-$631K	–	1607
2025 Q3	$631K	Buy	+5,909	New	+$617K	0.01%	532

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Graham Capital Management's VRNA Position: Q4 2025 in Review

Graham Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 5,909 shares — an estimated $631K sold.

Graham Capital Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $631K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Graham Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Graham Capital Management sold 5,909 Verona Pharma shares in Q4 2025, an estimated $631K.
Graham Capital Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Graham Capital Management's Verona Pharma position peaked at $631K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.